RBC Capital Maintains Outperform on HOOKIPA Pharma, Lowers Price Target to $5

HOOKIPA Pharma 0.00%

HOOKIPA Pharma

HOOK

0.80

0.00%

RBC Capital analyst Brian Abrahams maintains HOOKIPA Pharma (NASDAQ: HOOK) with a Outperform and lowers the price target from $6 to $5.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via